Conclusion
This study demonstrates that the use of dabigatran instead of warfarin in patients undergoing a DCCV, reduced rescheduling and, thus, improved efficiency. Future studies can examine if other new anticoagulants, such as direct factor Xa inhibitors, produce similar effects with elective DCCV.